WHAT YOU NEED TO KNOW: CAPA Dives Into What’s Driving Up Drug Prices: No-Innovation PatentingBrand name drug companies often attempt to bury competition from generic and biosimilar drugs indefinitely by finding ways to re-package existing inventions in later patents.  These later patents are often not innovative, meaning they are likely invalid.  A practice known as patent […]

Continue Reading

WHAT YOU NEED TO KNOW: IN CASE YOU MISSED IT: CAPA Executive Director Quoted In NYT Editorial Calling Out Patent Abuse & Highlighting Reforms to U.S. Patent System The New York Times recently published an editorial titled, “Save America’s Patent System” that focuses on measures lawmakers and regulators should take to reform the U.S. patent […]

Continue Reading